Tranquillisation or asleep · acute psychosis
Droperidol leads to higher tranquillisation or asleep: tranquillised/sleep ‐ by around 30 minutes compared with placebo (high certainty).
1 finding from 1 review
Adverse effects ‐ cardiovascular ‐ hypotension · acute psychosis
Droperidol showed no clear difference in adverse effects ‐ cardiovascular ‐ hypotension compared with haloperidol (moderate certainty).
1 finding from 1 review
Adverse effects ‐ cardiovascular ‐ hypotension/desaturation · acute psychosis
Droperidol showed no clear difference in adverse effects ‐ cardiovascular ‐ hypotension/desaturation compared with haloperidol (low certainty).
1 finding from 1 review
Service use: person able to be discharged home · acute psychosis
1 finding from 1 review
Mental state: mean score by 13 days (Scale for Quantification of Psychotic Symptom Severity, high = poor) · acute psychosis
Droperidol showed no clear difference in mental state: mean score by 13 days (Scale for Quantification of… compared with haloperidol (low certainty).
1 finding from 1 review
Economic: direct costs · acute psychosis
1 finding from 1 review
Tranquillisation or asleep · acute psychosis
Droperidol showed no clear difference in tranquillisation or asleep: tranquillised/asleep ‐ by 30 minutes (at… compared with midazolam (high certainty).
1 finding from 1 review
Global state: use of additional medication ‐ by 60 minutes after initial adequate sedation until ED discharge (various psychotropic drugs) · acute psychosis
Droperidol showed no clear difference in global state: use of additional medication ‐ by 60 minutes after… compared with midazolam (moderate certainty).
1 finding from 1 review
Adverse effects ‐ respiratory ‐ airway obstruction · acute psychosis
Droperidol showed no clear difference in adverse effects ‐ respiratory ‐ airway obstruction compared with midazolam (low certainty).
1 finding from 1 review
Adverse effects ‐ respiratory ‐ hypoxia · acute psychosis
Droperidol showed no clear difference in adverse effects ‐ respiratory ‐ hypoxia compared with midazolam (moderate certainty).
1 finding from 1 review
Service use: person able to be discharged home · acute psychosis
1 finding from 1 review
Global state: use of additional medication ‐ by 60 minutes after initial adequate sedation until ED discharge (various psychotropic drugs) · acute psychosis
Droperidol leads to lower global state: use of additional medication ‐ by 60 minutes after… compared with placebo (high certainty).
1 finding from 1 review
Mental state ‐ improvement · acute psychosis
1 finding from 1 review
Economic: direct costs · acute psychosis
1 finding from 1 review
Tranquillisation or asleep: tranquillised/asleep ‐ by around 30 minutes · acute psychosis
Droperidol showed no clear difference in tranquillisation or asleep: tranquillised/asleep ‐ by around 30… compared with olanzapine (high certainty).
1 finding from 1 review
Global state: use of additional medication ‐ by 60 minutes after initial adequate sedation until ED discharge (various psychotropic drugs) · acute psychosis
Droperidol leads to lower global state: use of additional medication ‐ by 60 minutes after… compared with olanzapine (high certainty).
1 finding from 1 review
Adverse effects ‐ cardiovascular ‐ arrhythmia · acute psychosis
Droperidol showed no clear difference in adverse effects ‐ cardiovascular ‐ arrhythmia compared with olanzapine (moderate certainty).
1 finding from 1 review
Adverse effects ‐ respiratory ‐ airway obstruction · acute psychosis
Droperidol showed no clear difference in adverse effects ‐ respiratory ‐ airway obstruction compared with olanzapine (low certainty).
1 finding from 1 review
Service use: person able to be discharged home · acute psychosis
Droperidol showed no clear difference in service use: person able to be discharged home compared with olanzapine (high certainty).
1 finding from 1 review
Mental state ‐ improvement · acute psychosis
1 finding from 1 review